Sexually Transmitted Disease Testing Market Share

  • Report ID: 4461
  • Published Date: Sep 09, 2025
  • Report Format: PDF, PPT

Sexually Transmitted Disease Testing Market Regional Analysis:

APAC Market Insights

The Asia Pacific STD Testing Market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2035. This can be attributed to the rising crimes related to sexual harassment in the region are increasing the chances of sexually transmitted disease along with the rising population, and the lack of sex education. In 2021, nearly 86 daily rapes and around 50 sexual crimes against women have been reported every hour in India. Moreover, in Thailand, the population of sex workers is around 250,000 to 2 million. Additionally, in 2021, over 20,000 deaths were caused by STDs in China, and nearly 20 thousand people died of AIDS.

North American Market Insights

On the other hand, the STD Testing Market in North America region is also expected to have a fastest growth owing to the increased incidence of STDs in the region. Moreover, there has been rising number of a substantial of clinical organizations and increased disease consciousness, that is anticipated to drive the market’s growth in the North American region. A survey released in April 2022 by the Centers for Disease Control and Prevention (CDC) titled "Sexually Transmitted Disease Surveillance, 2020" asserted that STDs persist as a major public health issue in the nation. Based on the same source, Chlamydia trachomatis disease was the highest common reportable sexually transmitted infection in the United States in 2020, with 1,579,885 people infected as per the CDC.

Sexually Transmitted Disease Testing Market Share

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of sexually transmitted disease testing is assessed at USD 11.57 billion.

The global sexually transmitted disease testing market size was valued at over USD 10.77 billion in 2025 and is expected to expand at a CAGR of around 8.3%, surpassing USD 23.91 billion revenue by 2035.

The Asia Pacific sexually transmitted disease testing market holds the largest share by 2035, driven by increasing STDs linked to sexual crimes and lack of sex education.

Key players in the market include Abbott Laboratories, bioMerieux, Becton Dickinson and Company, Quest Diagnostics, Thermo Fisher Scientific, Hologic Inc., Orasure Technologies, Inc., S&P Global, DiaSorin Molecular LLC.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos